The company’s mission is to deliver on the vast potential of its pioneering work in nitrase biology to discover and develop much-needed medicines for patients. Nitrases have been implicated in numerous devastating diseases, including Parkinson’s, cancer, respiratory diseases, fibrosis and other neurodegenerative diseases. Our wholly-owned first-in-class NITROME platform has generated leads for the inhibition of nitrase enzymatic reactions that can cause disease, and we believe that developing drugs based on the new knowledge of the role of protein nitration may result in therapeutic breakthroughs.